AdvaMed®DX Members
AdvaMedDx® members are medical technology firms that manufacture an in vitro diagnostic device or engage in research and development of such diagnostics.
Diagnostics
Learn more about our Diagnostics work.
AdvaMedDx®
AdvaMedDx® promotes innovation and expanded access to quality testing.
AdvaMed® Statement on Biden Administration Plan to Expand K-8 Testing
AdvaMed® released a response to the Biden administration’s announcement today of its plan to expand COVID-19 testing in our nation’s K-8 schools.
AdvaMed® Statement on Administration’s Expanded Investment in COVID Testing
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®)—the world’s largest trade association for medical technology and diagnostics companies in the world—released the following statement from President and CEO Scott Whitaker on…
AdvaMed® Re-Launches Web-Based Platform to Assist Government with Potential Supply Shortfalls
AdvaMed® unveiled a newly repurposed platform to help device manufacturers locate and partner with thousands of component part manufacturers and sellers, should they need them during the COVID pandemic.
AdvaMed® Announces 200 Million Molecular COVID-19 Tests Shipped Nationwide
WASHINGTON, D.C. –New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…
Weekly AdvaMed® COVID-19 Testing Registry Update: Over 190 Million Molecular Tests Shipped Nationwide
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 190 million. A breakdown of the data shows…
Weekly AdvaMed® COVID-19 Testing Registry Update: Over 180 Million Molecular Tests Shipped Nationwide
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 180 million. A breakdown of the data shows…
First “ABC”—Flu A/B + COVID-19—Rapid Antigen Test Authorized by FDA
“Game-changing” testing innovation from Quidel will save lives heading into flu season WASHINGTON, D.C. – AdvaMed® released the following statements on the announcement last night that Quidel Corporation, a member company of AdvaMed®…
Weekly AdvaMed® COVID-19 Testing Registry Update: 160 Million Molecular Tests Shipped Nationwide, 1.2 Million Daily
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 160 million. A breakdown of the data shows…